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Clinical / Scientific note
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Miller Fisher syndrome (MFS), considered a clinical 
variant of Guillain-Barré syndrome (GBS), is characterized 
by ophthalmoplegia, ataxia and areflexia1. Antecedent of 
respiratory and/or gastrointestinal symptoms is frequent 
(up to 70%), with an average symptom-free interval of 10 
days and the immune-mediated process is often associ-
ated with acute phase anti-GQ1b IgG antibodies in up to 
95% of all cases2. A closely related condition is Bicker-
staff’s brainstem encephalitis (BBE), which presents addi-
tionally alteration of consciousness or long tract signs, but 
is less frequently associated with anti-GQ1b antibodies3. 
Their relation and nosological position have been subject 
of extensive discussion in the literature. Idiopathic intra-
cranial hypertension (IIH) comprises signs of increased in-
tracranial pressure occurring in the absence of obvious ce-
rebral pathology4. Some studies have reported cases of 
intracranial hypertension associated with GBS, very few 
with MFS, but none with BBE. 
We describe a distinct patient presenting initially with 
typical IIH findings but developing later signs of BBE, MFS 
and GBS. We also review evidence toward the possible 
link among MFS, BBE and GBS.
CaSe 
An obese 15 year-old female presented with a 5-days his-
tory of frontal headache, nausea, vomiting and diplopia. Two 
weeks earlier she had had flu-like symptoms and diarrhea. Ex-
amination disclosed normal consciousness, right sixth nerve pal-
sy and bilateral papilledema (Fig 1) with normal visual acuity. Ce-
rebral CT and MRI were normal. Lumbar puncture performed in 
the first hospitalization day revealed an opening pressure of 100 
cm H2O, and 25 mL of cerebrospinal fluid (CSF) were withdrawn. 
CSF protein and cell count were 15 mg/dL and two cells per 
mm3, respectively (Table). Despite a transient relief, the symp-
toms relapsed and acetazolamide-corticosteroid combination 
was begun for the hypothesis of IIH. Two days later she devel-
Fig 1. Papilledema at presentation: right (A) and left (B) eye.
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oped incomplete left third nerve palsy with affected visual acu-
ity and visual field (Fig 2A). On the next day, drowsiness was ob-
served. The symptoms worsened and on the sixth day she had a 
Glasgow Coma Scale (GCS) score of 11, areflexia, muscle weak-
ness (grade 4 on the Medical Research Council scale), urinary re-
tention and mild cerebellar ataxia. Normal laboratorial investi-
gation excluded metabolic encephalopathy. New CSF analysis 
(at the 10th hospitalization day) showed increased protein with 
minimal pleocytosis. Serology for acute viral and bacterial in-
fection was negative. Anti-GQ1b antibodies were not detected. 
Electrophysiology disclosed reduction in the amplitude of mus-
cle action potential in facial nerves, right median and right ulnar 
nerves, besides slowed motor nerve conduction velocity in right 
ulnar nerve and diffusely absent F-responses and H-reflex. She 
was diagnosed with BBE and treated with intravenous gamma-
globulin (0.4g/Kg/day for 5 days). One week later she had a GCS 
of 15 and recovered almost completely from her ataxia, muscle 
weakness and urinary retention. One month later she had only 
a mild right sixth nerve palsy and areflexia with improved visu-
al acuity and campimetry (Fig 2B). Five months later the Achil-
les reflex was present, though decreased. 
A written informed consent to publish the case report was 
given by the patient and her legal responsible. 
diSCuSSion
The initial clinical picture of this patient fulfilled the 
modified Dandy criteria for IHH. This syndrome, first de-
scribed more than 100 years ago, is particularly frequent 
in overweight adolescent girls and is associated with dif-
ferent conditions such as medications, polycystic ovary 
syndrome and menstrual dysfunction4. The pathophysi-
ology of increased CSF pressure has not yet been com-
pletely elucidated and different mechanisms have been 
proposed, such as increased cerebral volume, CSF produc-
tion rate and cerebral venous pressure, but impaired CSF 
outflow into the venous system does play an important 
role5. The course is usually benign, though sometimes it 
can be complicated with visual loss4.
Our patient, however, showed an atypical evolution. 
Within 1-week period she developed weakness, drowsi-
ness and ophthalmoplegia, features of GBS, BBE and MFS, 
respectively. In GBS, co-occurrence of intracranial hyper-
tension has been documented, with papilledema found 
in about 4% of affected children, and less frequently in 
adults6. Although high protein content has been related 
to the mechanism of pseudotumor in GBS, it does not 
always play a major role7, since intracranial hypertension 
has also been observed in patients with only mildly or 
moderately elevated CSF protein content, as in our case. 
Other mechanisms such as an immune-mediated impair-
ment of CSF outflow into the venous system may also be 
related. In MFS, few cases showing signs of elevated intra-
cranial pressure have been documented in the literature8, 
but, to our knowledge, it has never been described with 
BBE. This association may be under recognized since oph-
thalmoscopy and CSF pressure are not routinely assessed 
in MFS, BBE or GBS.
Table. Cerebrospinal fluid parameters through disease evolution.
CSF parameters D1 D4 D10 D25 D90
Opening pressure (cm H2O) 100 95 37 15 ND
Total protein (mg/L) 15 ND 70 88 39
Glucose (mg/L) 63 ND 99 70 54
Cell count (cells/mm3) 2 ND 5 4 5
ND, not done; D1, D4, D10, D25, and D90, days of hospitalization; numbers 
1, 4, 10, 25, and 90, respectively.
Fig 2. Right eye campimetry performed at the forth (A) and the thirtieth (B) day of hospitalization.
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The classic triad of ophthalmoplegia, ataxia and are-
flexia was first described in 1956 by Fisher, who regarded 
it as an unusual variant of GBS resulting from peripheral 
nerve injury9. Interestingly, one of his patients had drowsi-
ness. One year later, Bickerstaff continued his previous 
work and reported eight patients with acute ophthalmo-
plegia, ataxia and altered consciousness, considering this 
syndrome as a form of encephalitis10. Four of his patients 
had areflexia. Due to the similarities of these syndromes, 
much begun to be debated in literature, from being or 
not variants of the same spectrum to their nosological 
position as either peripheral or central11. An important 
contribution was the finding of an antibody that reacts 
with peripheral nerve ganglioside GQ1b in a great number 
of patients with MFS12 and some with BBE3. Further ob-
servations related this antibody to the presence of oph-
thalmoplegia and ataxia. Greater amounts of ganglioside 
GQ1b have been found in cranial nerves III, IV and VI12 and 
these nerves were enhanced by gadolinium on MRI in pa-
tients with MFS13. A selective staining of the cerebellar 
molecular layer by serum IgG antiGQ1b has also been ob-
served14. Although the presence of this antibody could 
be a secondary phenomenon due to destruction of neu-
rons, some evidence points to a pathogenetic role, with 
blocking effects on the neuromuscular transmission15. The 
appearance of this antibody has been related to cross re-
activity with lipopolysaccharide in the bacterial coat of 
Campylobacter jejuni, especially those with a particular 
polymorphism (Asn51) of cst-II gene16. The anti-GQ1b an-
tibodies were not detected in our patient, pointing more 
to the BBE side of the possible “MFS-BBE spectrum”. 
Another valuable contribution came from studies with 
brain imaging describing abnormalities in some cases of 
BBE. In about 30% of the patients, high-signal lesions on 
T2-weighted scans were found in the brainstem, thala-
mus, cerebellum and cerebrum3. A study with PET scan 
also found involvement of brainstem and cerebellum17. 
Similar findings have also been reported in patients diag-
nosed with MFS18, even in the absence of drowsiness or 
long tract signs, pointing to a central involvement in both 
MFS and BBE. Also supporting the spectrum hypothesis 
has been the evidence of concomitant central and pe-
ripheral abnormalities described by Ogawara et al.19. More, 
symptoms of central involvement in MFS, such as a mild 
somnolence, may not always be recognized.
The relation of these syndromes to GBS has been pro-
posed since the first description of Bickerstaff and Fisher, 
and supported by several overlapping cases3 describing the 
presence of muscle weakness and albuminocytologic dis-
sociation in addition to the classic triad of Fisher and/or 
altered consciousness or extensor plantar responses. The 
prognosis, however, is usually benign, especially in the “clas-
sic” MFS2, and while in GBS treatment with plasmapheresis 
or immunoglobulin is widely recommended1, in MFS they 
are not always necessary2. In BBE or MFS/BBE overlapping 
cases, this treatment has been associated with beneficial 
effects, but randomized controlled trials are needed to 
establish the value of immunotherapies or other treat-
ments20. Our patient received a 5-days course of immuno-
globulin, but her improvement may be attributed either 
to the natural history of the disease or to the treatment.
Finally, this case shows a remarkable presentation of 
BBE with intracranial hypertension, a condition previously 
associated with GBS or MFS alone. It also contributes to 
the understanding of the “MFS-BBE spectrum” or acute 
inflammatory encephaloradiculoneuritis, which may be 
considered as a variant of GBS, presenting both peripheral 
and central involvement.
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